1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)" is currently closed and not accepting applications.
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) is sponsored by National Institute of Child Health and Human Development (NICHD).
This funding opportunity aims to utilize NICHD clinical research network infrastructure for investigator-initiated, multisite clinical trials and observational studies relevant to infants, children, women (including those pregnant and lactating), and persons with disabilities. Argininosuccinic aciduria is a rare genetic disorder affecting children, fitting within NICHD's mission to lead research and training on the health of children.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) | Research Funding National Institutes of Health Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research network infrastructure relevant to infants, children, women, including those who are pregnant and lactating, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies.
This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical study implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases.
A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community.
Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.
Application Due Dates: March 14, 2025; July 15, 2025; Nov 14, 2025; March 15, 2026; July 15, 2026; Nov 13, 2026; March 15, 2027; July 15, 2027; Nov 15, 2027 AIDS Application Due Dates: March 14, 2025; July 15, 2025; Nov 14, 2025; March 15, 2026; July 15, 2026; Nov 13, 2026; March 15, 2027; July 15, 2027; Nov 15, 2027 PAR-25-311 Expiration Date November 16, 2027 Application budgets are limited to direct costs of $6,250,000 for the entire project period (both phases), but need to reflect the actual needs of the proposed project.
Direct costs should include capitation dollars to conduct the research. Projects requiring direct costs exceeding $6,250,000 may be proposed, but will require additional NICHD approval as part of the pre-application process. Medical - Clinical Science
According to the current listing, eligibility includes: This NOFO provides an opportunity to leverage NICHD clinical research network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD. Confirm the full requirements in the official notice before applying.
The published deadline was December 16, 2024, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) is funded by National Institute of Child Health and Human Development (NICHD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read article